HSPB1 and myeloid sarcoma: HSPB1 is associated with senile plaques in AD and prevents the toxic effects of Aβ aggregates in vitro [67], and was found to be a key molecule in a regulatory network analysis integrating AD, Parkinson’s and MS [68].